Bioavailability
AustinPx Expands KinetiSol™ Technology Commercial Access through Thermo Fisher Scientific Collaboration
AustinPx
PR-06-26-03Jun 30, 2026
Research Collab
10x Genomics and Cleveland Clinic Collaborate in Diagnostic Applications of Single Cell and Spatial Technologies in Bladder Cancer
10x Genomics
PR-06-26-02Jun 17, 2026
CNS Clinical
Insilico Completes First-in-Human Dosing in Phase I Clinical Study of AI-Driven NLRP3 Inhibitor ISM8969
Insilico Medicine
PR-06-26-01Jun 17, 2026
Partnership
The Solubility Company and Persist AI Unveil Strategic Partnership to Bridge the Data Gap in AI-Driven Drug Formulation
The Solubility Company
PR-05-26-02May 13, 2026
Lab Software
Lab Thread Introduces Unified Lab Software Platform to Streamline Biological Research
Lab Thread
PR-05-26-01May 8, 2026
Microbiome
Zymo Research Launches Fecal Microbiome Discovery Grant to Enable the Next Breakthroughs in Human Health
Zymo Research Corp.
PR-04-26-10Apr 24, 2026
Proteomics
RareCyte Expands Clinical-Scale Spatial Proteomics Portfolio with New Orion Systems and Leadership Appointment
RareCyte
PR-04-26-09Apr 20, 2026
Fluid Management
Introducing CPC Biotech - One Brand Uniting Critical Fluid Management Components
PR-04-26-08Apr 16, 2026
Appointment
Dr.Evidence Appoints David Pennington as Chief Executive Officer
Dr.Evidence
PR-04-26-07Apr 9, 2026
Intercellular
Transferring Cytoplasmic Contents and Organelles Between Living Cells
Waseda University
PR-04-26-06Apr 3, 2026
Formulation
Quotient Sciences and Intrepid Labs form Strategic Partnership to Accelerate AI-guided Formulation Development
Quotient Sciences
PR-04-26-05Apr 1, 2026
Clinical Partnership
Quotient Sciences and Biorasi Partner to Accelerate Early Phase Clinical Trials to Patient Proof-of-Concept
Quotient Sciences
PR-04-26-04Apr 1, 2026
Drug Development
Lindus Health and Quotient Sciences Partner to Accelerate Drug Development from First-in-Human to Pivotal Trials
Quotient Sciences
PR-04-26-03Apr 1, 2026
Rare Disease
Quotient Sciences Extends Commercial Manufacturing Partnership for Ultra-Rare Disease Treatment
Quotient Sciences
PR-04-26-02Apr 1, 2026
M&A
ROIS CDMO Closes on the Acquisition of US Injectable Manufacturing Facility
ROIS
PR-04-26-01Apr 1, 2026
M&A
Samsung Biologics Completes Acquisition of GSK’s Manufacturing Facility in Rockville, Maryland
Samsung Biologics
PR-03-26-02Mar 31, 2026
Lab Software
Lab Thread Launches Free Version of Unified Lab Software Platform to Accelerate Academic Research
Lab Thread
PR-03-26-01Mar 16, 2026
Expansion
Codis Unlocks Commercial-Scale Amorphous Solid Dispersions Manufacturing with GEA PSD4 Solvent Spray Dryer Investment
Codis
PR-02-26-08Mar 4, 2026
Distribution
Univar Solutions Selected as Ingredion Pharma Solutions Distributor in United States and Canada
Ingredients + Specialties from Univar Solutions
PR-02-26-07Feb 25, 2026
FDA Inspection
Flamma USA Successfully Passes FDA Inspection
Flamma Group
PR-02-26-06Feb 25, 2026